The study of neurodegenerative diseases delves into the intricate processes of neuronal decline and dysfunction, exploring the mechanisms behind disorders like amyotrophic lateral sclerosis, multiple sclerosis, and frontotemporal dementia. Cutting-edge research highlights the role of protein misfolding, mitochondrial dysfunction, and neuroinflammation in disease pathology. Therapies targeting these pathways, including small molecules, gene therapies, and stem cell-based treatments, are at the forefront of clinical trials. Efforts to integrate neuroimaging and computational models enhance the understanding of disease progression, enabling the design of precise therapeutic interventions. Collaborative advancements are reshaping the future of managing and potentially reversing the effects of these complex disorders.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : How have we eliminated infection: From the bone to brain ?
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cervical stenosis-induced chronic cerebrospinal fluid flow restriction as a contributing cause of dementia
Joe Sam Robinson, Mercer University, United States